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Abstract 
In a multicenter setting, we applied voxel-based methods to different structural MR imaging 
modalities to define the relative contributions of focal lesions, normal-appearing white matter 
(NAWM) and gray matter (GM) damage and their regional distribution to cognitive deficits as well 
as impairment of specific cognitive domains in multiple sclerosis (MS) patients.  
Approval of the institutional review boards was obtained, together with written informed 
consent from all participants. Standardized neuropsychological assessment and conventional, 
diffusion tensor and volumetric brain MRI sequences were collected from 61 relapsing-remitting 
MS patients and 61 healthy controls (HC) from seven centers. Patients with ≥2 abnormal tests were 
considered cognitively impaired (CI). The distribution of focal lesions, GM and WM atrophy and 
microstructural WM damage were assessed using voxel-wise approaches. A random forest analysis 
identified the best imaging predictors of global cognitive impairment and deficits of specific 
cognitive domains. 
Twenty-three (38%) MS patients were CI. Compared to cognitively preserved (CP), CI MS 
patients had GM atrophy of the left thalamus, right hippocampus and parietal regions. They also 
showed atrophy of several WM tracts, mainly located in posterior brain regions and widespread 
WM diffusivity abnormalities. WM diffusivity abnormalities in cognitive-relevant WM tracts 
followed by atrophy of cognitive-relevant GM regions explained global cognitive impairment. 
Variable patterns of NAWM and GM damage were associated with deficits in selected cognitive 
domains. 
Structural, multiparametric, voxel-wise MRI approaches are feasible in a multicenter setting. 
The combination of different images modalities is needed to assess and monitor cognitive 
impairment in MS.  
Key words: multiple sclerosis, cognitive impairment, diffusion tensor MRI, atrophy, voxel-wise 
analysis, multicenter. 
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Introduction 
The definition of the mechanisms responsible for the presence and severity of cognitive 
impairment in multiple sclerosis (MS) patients is of paramount importance, given the high 
frequency  from of such an impairment in this condition, ranging from 40 to 70% (Chiaravalloti and 
DeLuca, 2008), and the dramatic impact cognitive dysfunction has on activities and quality of life 
of patients and their caregivers.  
MRI is extremely sensitive in detecting MS related tissue abnormalities, and, during the past 
decades, several quantitative MRI techniques, capable to estimate different aspects of MS pathology 
have been developed and are currently being used. The application of these techniques to define the 
structural MRI correlates of cognitive impairment in different cohort of MS patients has shown that 
global and regional damage of brain white matter (WM) and gray matter (GM) in terms of focal 
lesions (Calabrese, et al., 2012; Roosendaal, et al., 2009; Rossi, et al., 2012), diffuse microstructural 
abnormalities (Dineen, et al., 2009; Hulst, et al., 2013; Mesaros, et al., 2012), and irreversible tissue 
loss (Amato, et al., 2007; Calabrese, et al., 2010b) play a significant role for the presence and 
severity of cognitive impairment. 
Only a few studies have integrated measures of focal lesions, normal-appearing (NA) WM 
injury and GM involvement to assess the relative contribution of each of these factors to cognitive 
deficits in MS (Hulst, et al., 2013; Llufriu, et al., 2014). Interestingly, these studies showed that 
damage of WM tracts, quantified using diffusion tensor (DT) MRI, influences significantly 
cognitive performance in MS, whereas GM damage seems to add no (Hulst, et al., 2013) or only a 
small increment to the variance explained by WM damage (Llufriu, et al., 2014).  
To identify objective outcome measures of cognitive impairment to be applied not only for 
patients monitoring, but also as a target for innovative treatment strategies, several unmet needs still 
remain. These include the confirmation of the previous findings in different cohorts of patients and 
their validation in a multicenter context.  
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Against this background, we applied voxel-based methods to different structural MRI 
modalities to define the relative contributions of focal lesions, NAWM and GM damage and their 
regional distribution to cognitive deficits as well as impairment of specific cognitive domains in MS 
patients in a multicenter setting.  
 
Materials and methods 
This study was approved by the Local Ethical Committes on human studies in each 
participant center and written informed consent from each subject was obtained prior to their 
enrolment. 
Subjects. Subjects were recruited from January 2009 to May 2012 as part of a project on 
imaging correlates of cognitive impairment in MS at seven European centers (www.magnims.eu), 
which included: a) the Department of Radiology, VU University Medical Centre, Amsterdam 
(Netherlands) (9 healthy controls [HC] and 8 MS patients); b) the CEM-Cat, Hospital Vall 
d’Hebron, Barcelona (Spain) (3 HC and 8 MS patients); c) the Research Unit for Neuronal Repair 
and Plasticity at the Dept. of Neurology, Medical University of Graz, Graz (Austria) (12 HC and 7 
MS patients); d) the Queen Square Imaging Centre, Institute of Neurology, University College 
London, London (UK) (9 HC and 7 MS patients); e) the Neuroimaging Research Unit, San Raffaele 
Scientific Institute, Milan (Italy) (10 HC and 10 MS patients); f) the MRI Center “SUNFISM”, 
Second University of Naples, Naples (Italy) (8 HC and 11 MS patients); and g) the Department of 
Neurological and Behavioral Sciences, University of Siena, Siena, Italy (10 HC and 10 MS 
patients).   
The inclusion criteria for this study required all subjects to be right-handed and aged 
between 20 and 65 years. In addition, patients had to have a diagnosis of relapsing remitting (RR) 
MS (Lublin, et al., 2014; Polman, et al., 2011), no relapse or corticosteroids treatment within the 
month prior to scanning and no history of psychiatric conditions, including major depression. 
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The final dataset used for this analysis included 61 RRMS patients (21/40 men/women; 
mean age = 39.7 years, standard deviation [SD] = 8.5 years; mean disease duration = 8.2 years, 
range = 2-33 years; median Expanded Disability Status Scale [EDSS] score = 1.5, range = 0.0-6.0) 
and 61 healthy controls (HC) (26/35 men/women, mean age = 36.0 years, SD = 9.5 years). Sex did 
not differ significantly between HCs and MS patients (p=0.3), whereas HCs were significantly 
younger than MS patients (p=0.02) and had more years of education (p<0.0001). As a consequence 
age was included as a covariate in all statistical models.  
Clinical and neuropsychological assessment. Within 48 hours from the MRI acquisition, MS 
patients underwent a neurological evaluation with rating of the EDSS score and a 
neuropsychological assessment, performed at each participating site by an experienced neurologist 
and neuropsychologist, unaware of the MRI results, using validated translations of the 
neuropsychological tests. Cognitive performance was assessed using the Brief Repeatable Battery 
of Neuropsychological Tests (BRB-N) (Rao, 1991), only marginally influenced by language or 
cultural differences (Sepulcre, et al., 2006). BRB-N includes the Selective Reminding Test (SRT), 
to assess verbal memory; the 10/36 Spatial Recall Test (10/36 SRT), to assess visual memory; the 
Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) 2” 
and 3”, to assess attention and information processing speed; and the Word List Generation (WLG) 
test, to assess verbal fluency. As previously described (Rocca, et al., 2014; Sepulcre, et al., 2006), 
raw data were corrected according to normative values and Z-scores for each of the previous 
domains were calculated. 
In addition, the Wisconsin Card Sorting Test (WCST) was administered to evaluate 
executive functions (Heaton, 1993). Performance at the WCST was evaluated by computing scores 
related to the total errors (WCSTte), the number of perseverative errors (WCSTpe), and the number 
of perseverative responses (WCSTpr). Patients with a score  2SD in at least one of these measures 
were considered impaired at the WCST (Mattioli, et al., 2010). 
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Patients were considered as cognitively impaired (CI) if they had at least two abnormal tests 
(defined as a score more than 2 SDs below the normative value provided by Boringa et al. (Boringa, 
et al., 2001) for the BRB-N and by Heaton et al. (Heaton, 1993) for the WCST).  
MRI acquisition. Brain MRI scans were obtained using magnets operating at 3 Tesla at all 
sites (Amsterdam and Naples: GE Signa; Barcelona, Graz and London: Siemens Trio; Milan and 
Siena: Philips Intera). The following sequences were collected during a single session: a) dual-echo 
turbo-spin-echo (TSE): TR=ranging from 4000 to 5380 ms, TE1=ranging from 10 to 23 ms, 
TE2=ranging from 90 to 102 ms, echo train length (ETL)=ranging from 5 to 11, 44 contiguous, 3-
mm thick axial slices, parallel to the AC-PC plane, with a matrix size=256x192 and a FOV= 
240x180 mm2 (recFOV=75%); b) 3D T1-weighted scan: TR=ranging from 5.5 to 8.3 ms (for 
GE/Philips scanners) and from 1900 to 2300 ms (for Siemens scanners); TE=ranging from 1.7 to 
3.0 ms; flip angle ranging from 8° to 12°, 176 to 192 sagittal slices with thickness=1 mm and in-
plane resolution=1x1 mm2; c) pulsed gradient spin echo (PGSE) (Stejskal, 1965) single-shot echo 
planar imaging (SS-EPI) sequence with a double-refocused variant (Reese, et al., 2003) on all 
Siemens scanners to minimize eddy-current distortions, and single-echo EPI acquisition on all 
Philips scanners. The following target scan parameters were used: TR: 6000–12000 ms; TE: 70–100 
ms, FOV: 320x240 mm2; acquisition matrix: 128x96, 50 slices with an isotropic resolution (cubic 
voxels) of 2.5 mm. Thirty DW volumes (Jones, 2004) were acquired, each with a different diffusion 
encoding gradient vector direction, and with a constant b-factor of 900 s/mm2. On scanners where it 
was not possible to use 30 directions because of pulse sequence limitations, the maximum number 
available was used, but with an increased number of repetitions such that the product of the number 
of DW directions and the number of repetitions was kept close to 30. Parallel acquisition with a 
reduction factor=2 was used (Pagani, et al., 2010). 
MRI analysis. MRI data analysis was done centrally at the Neuroimaging Research Unit 
(Milan, Italy) by experienced observers blinded to subjects’ identity. 
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Brain T2-hyperintense and T1-hypointense lesion volumes (LV) were measured on dual-
echo TSE and 3D T1-weighted scans, respectively, using a local thresholding segmentation 
technique (Jim 6.0, Xinapse Systems, West Bergholt, UK). Normalized brain (NBV), WM (WMV) 
and GM (GMV) volumes were measured on 3D T1-weighted scans using the SIENAx software, 
after T1-hypointense lesion refilling (Chard, et al., 2010). In MS patients, to create maps of T2-
hyperintense lesions, binarized masks from T2 lesions were obtained, coregistered to the 3D T1-
weighted scans (using the rigid transformation calculated between the T2-weighted and the 3D T1-
weighted image), normalized to the standard SPM space (using the DARTEL non-linear 
transformation calculated for the Voxel-Based Morphometry [VBM] analysis), and averaged to 
obtain T2 lesion probability maps (LPMs). 
VBM analysis was performed using SPM8. First, 3D T1-weighted images were segmented 
into GM, WM and cerebrospinal fluid (CSF). Then, GM and WM segmented images of all subjects, 
in the closest possible rigid-body alignment with each other, were used to produce GM and WM 
templates and to drive the deformation to the templates. At each iteration, the deformations, 
calculated using the Diffeomorphic Anatomical Registration using Exponentiated Lie algebra 
(DARTEL) registration method, were applied to GM and WM, with an increasingly good alignment 
of subject morphology, to produce the templates. Spatially normalized images were then modulated 
to ensure that the overall amount of each tissue class was not altered by the spatial normalization 
procedure. To better align the final template with the Montreal Neurologic Institute (MNI) space, an 
affine registration between the customized GM template and the SPM GM template (in the MNI 
space) was also calculated and added to the header of each image as a new orientation, in order to 
have all the images in a standard space. The same transformation was applied to the WM 
customized template. The images were then smoothed with an 8 mm FWHM Gaussian kernel. 
Diffusion-weighted images were first corrected for distortions caused by the eddy currents, 
for movements and transformed to MNI space (http://white.stanford.edu/mrdiff). Then, using the 
FMRIB’s Diffusion Toolbox (FDT tool, FSL 4.1, http://www.fmrib.ox.ac.uk), the diffusion tensor 
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(DT) was estimated in each voxel using a linear regression (Basser, et al., 1994) and mean 
diffusivity (MD) and fractional anisotropy (FA) maps were derived. GM and WM probability maps 
previously segmented from 3DT1-weighted scans were transformed to DT space, concatenating the 
rigid transformation between 3D T1-weighted scans and T2-weighted scans and the non linear 
transformation between T2-weighted scans and b=0 images. This second transformation, useful to 
compensate off resonance distortions was obtained using FNIRT from FSL Library. Average FA 
and MD values in the NAWM were obtained, masking out T2 lesions. Average MD values in the 
GM were also calculated. 
For voxel-wise analysis, FA maps were transformed using FNIRT on FMRIB58_FA atlas, 
smoothed and statistically analyzed with SPM8, with the application of a WM mask, in order to 
consider only NAWM. The same procedure was used for MD. 
Statistical analysis. Patients’ clinical and MRI characteristics were reported as medians and 
ranges or as frequencies and percentages for continuous and categorical variables, respectively. 
Between-group and between-center comparisons were performed using the Pearson chi-squared test 
and Mann-Whitney U-test or Kruskal-Wallis test for categorical and continuous variables, 
respectively.  
Between-group (MS patients vs HC and CI vs cognitively preserved [CP] MS patients) 
comparison of T2 LPMs, GM atrophy, WM atrophy and diffusivity abnormalities was performed 
using SPM8 and a full factorial analysis of covariance, considering group and center as factors, and 
including age and sex as covariates. Analyses were repeated including also education as covariate. 
For the analysis of atrophy, the normalization factor derived from SIENAx (which can be 
considered as a measure of head size) was also included. Multiple linear regression models, 
adjusted for age, sex and center, were used to assess the correlation between regional brain damage 
and neuropsychological variables (z scores of individual cognitive domains and WCST). Analyses 
were repeated considering also education as covariate. For all analyses run with SPM8, results were 
tested both at p < 0.001, uncorrected, and at p < 0.05, family-wise error (FWE) corrected (cluster 
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extent of = 5 voxels). The localization of areas of WM and GM atrophy and of diffusivity 
abnormalities was defined using available atlases (Mori, 2005; Tzourio-Mazoyer, et al., 2002). 
A random forest analysis (RF) was run to identify the best predictors, among all MRI 
variables explored, of global cognitive impairment as well as impairment of specific cognitive 
domains (Breiman, 2001; Mesaros, et al., 2012). An output of the RF corresponds to variable 
importance reported as a ranking: each covariate receives a score according to its ability to classify 
or to predict correctly the patient’s outcome when data are permuted. For convenience of 
interpretation, variable importance was normalized with respect to the best predictor. For the RF 
analysis, MRI measures which were significantly different between CI and CP MS patients and HC 
and those which showed significant correlation with neuropsychological scores were considered. C-
statistics and R2 were also reported for dichotomous and continuous outcomes, respectively.  
 
Results 
Clinical, neuropsychological, and conventional MRI measures. Table 1 summarizes the 
main demographic, clinical and MRI characteristics of MS patients and HC. Twenty-three (38%) 
MS patients were classified as CI. The cognitive domains most frequently involved were attention 
and information processing speed (33% of the patients), executive functions (23%), verbal fluency 
(21%), verbal memory (18%) and visual memory (16%). 
Compared to HC, MS patients had lower NBV (p<0.0001), GMV (p<0.0001), WMV 
(p<0.0001), WM FA (p=0.0001) as well as higher WM MD (p=0.03) and GM MD (p=0.02). A 
significant center effect was found for age (p=0.005), EDSS (p=0.01), NBV (p<0.0001), GMV 
(p=0.0001), WMV (p=0.04), WM MD (p<0.0001) and WM FA (p<0.0001); whereas no effect was 
found for sex (p=0.21), education (p=0.06), disease duration (p=0.18), T2 LV (p=0.17), and T1 LV 
(p=0.21).  
Compared to HC, both CP and CI MS patients had fewer years of education (p 
values=0.0001 for CP MS patients and 0.001 for CI MS patients), lower NBV, GMV and WMV (p 
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values ranging from <0.0001 to 0.005), and lower WM FA (p values=0.005 and 0.0002). Compared 
to HC, CI MS patients were also older (p=0.001). Compared to CP, CI MS patients were older 
(p=0.01), had higher EDSS (p=0.04), T2 LV (p=0.01) and T1 LV (p=0.008), as well as lower NBV 
(p=0.02) and GMV (p=0.01). 
LPMs. In MS patients, T2-hyperintense lesions were mostly located in the periventricular 
WM and corona radiate, bilaterally. Compared to CP, CI MS patients showed a significantly higher 
T2 lesion frequency in periventricular regions and several WM tracts, including the inferior fronto-
occipital fasciculus (IFOF), corona radiata, cingulum, corpus callosum (CC), inferior (ILF) and 
superior (SLF) longitudinal fasciculus, forceps major and minor and anterior thalamic radiation 
(ATR), bilaterally (Figures 1 and 2) (p<0.001 uncorrected). 
VBM. Table 2 and Figure 1 summarize the results of GM and WM atrophy distribution 
among the different study groups. Compared to HC, both CP and CI MS patients showed diffuse 
GM atrophy involving deep GM nuclei, several fronto-parieto-temporal-occipital regions, the 
cingulate cortex, and cerebellum bilaterally. They also showed diffuse WM atrophy, involving the 
majority of brain WM tracts (p<0.001).  
Compared to CP, CI MS patients showed significant GM atrophy of the bilateral postcentral 
gyrus, left (L) thalamus, L supramarginal gyrus and R hippocampus. They also showed significant 
atrophy of several clusters located in different WM tracts, including the ILF, IFOF, SLF, ATR 
bilaterally, L cingulum, R splenium of the CC, fornix and R uncinate fasciculus (p<0.001). Such 
volume differences were only partially overlapping with T2 LPM differences (Table 2 and Figure 
1).  Similar results were obtained when including education as a covariate (data not shown). 
Voxel-wise analysis of DT MRI abnormalities. Table 3 and Figure 2 summarize the results 
of MD and FA abnormalities distribution among the different study groups (p<0.05 FWE 
corrected). Compared to HC, both CP and CI MS patients showed an increased MD in several WM 
tracts, including the CC, cingulum, corona radiata, ILF, IFOF, and SLF bilaterally. They also 
showed decreased FA in the majority of WM tracts. Compared to CP, CI MS patients showed an 
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increased MD of the majority of WM tracts, while FA abnormalities were more limited, with the 
involvement of bilateral IFOF, bilateral ILF, R forceps major, R cingulum and L SLF (Table 3 and 
Figure 2). Such diffusivity abnormalities were only partially overlapping with T2 LPM differences 
(Table 3 and Figure 2). Similar results were obtained when including education as a covariate (data 
not shown). 
Analysis of correlations. In MS patients, GM and WM atrophy of several brain regions were 
significantly correlated with performances in different cognitive domains (r values ranging from 
0.69 to 0.48; p<0.001 uncorrected) (Figure 3, Table 4). No correlation was found between regional 
GM atrophy and verbal memory performance as well as between regional WM atrophy and verbal 
memory, fluency and WCST performances. Similar results were obtained when including education 
as a covariate (data not shown). 
In MS patients, MD and FA abnormalities of several brain WM tracts were significantly 
correlated with performances in different cognitive domains (r values ranging from -0.66 to 0.71; 
p<0.001 uncorrected) (Figure 4, Table 5). No correlation was found between diffusivity measures 
and performance at verbal memory and fluency. 
Multimodal analysis. Figure 5 summarizes the results of RF analysis performed 
to identify the MRI variables significantly associated with the presence of cognitive impairment as 
well as with performance at specific cognitive domains. For each cognitive variable, the five most 
important MRI predictors are listed. The best predictors of global cognitive impairment were L SLF 
FA (C-statistic=0.89), R cingulum FA (C-statistic=0.85), L posterior corona radiata MD (C-
statistic=0.82), L postcentral gyrus atrophy (C-statistic=0.86) and R hippocampal atrophy (C-
statistic=0.82) (in this order of ranking). 
Considering performance at specific cognitive domains, impairment of attention/information 
processing speed was predicted by R ILF FA (R2=0.30), followed by R inferior frontal gyrus (IFG) 
atrophy (R2=0.27) and left thalamus atrophy (R2=0.29); visual memory impairment was associated 
with atrophy of the splenium of the CC (R2=0.24) and L ILF (R2=0.22); verbal fluency impairment 
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was predicted by R insula (R2=0.08) and L postcentral gyrus atrophy (R2=0.07); finally executive 
function deficits were associated with R IFG atrophy (R2=0.14) and L IFOF MD (R2=0.13). 
The analysis was not performed for verbal memory, since no cluster resulted significantly 
correlated with their z scores. 
 
Discussion 
By combining voxel-wise analysis methods and a multiparametric structural MRI approach, 
which included both measures of irreversible tissue loss and microstructural tissue damage, this 
study proves the applicability of these techniques in a multicenter setting and shows that CI in this 
condition is the result of a complex interplay between NAWM and GM damage. Our results also 
support the notion that different substrates are likely to contribute to global CI and impairment of 
specific cognitive domains in these patients. Indeed, when considering global CI, WM diffusivity 
abnormalities in cognitive-relevant WM tracts followed by atrophy of critical GM regions had the 
highest relevance to explain cognitive performance, possibly as a consequence of a disconnection 
syndrome occurring between GM regions following WM damage. Conversely, impairment of 
selected cognitive domains was associated with variable patterns of NAWM and GM damage, 
reflecting structural damage to regions with a critical role for the studied function. All of this 
suggests that the use of a single MR modality is not sufficient to properly explain cognitive 
impairment in MS and to monitor its progression and the effects of therapeutic interventions, but a 
multimodal imaging approach is needed.  
In agreement with the results from previous studies (Dineen, et al., 2009; Hulst, et al., 2013; 
Mesaros, et al., 2012; Roosendaal, et al., 2009) and with that of a recent meta-analysis (Welton, et 
al., 2015) which after including data from 12 MS studies (495 MS patients and 253 HC) has 
suggested that brain WM damage is more functionally relevant for cognitive dysfunction than for 
physical disability, we found that, compared to HC and CP patients, CI MS patients had increased 
MD of the majority of WM tracts as well as reduced FA of the L IFOF, R ILF, L SLF and R 
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anterior cingulum. Moreover, diffusivity abnormalities of several clusters in cognitive-relevant WM 
tracts significantly correlated with performance at different cognitive domains, except for verbal 
memory and fluency. The relevance of WM diffusivity abnormalities in explaining cognitive 
impairment is further supported by the RF analysis, which showed that diffusivity abnormalities of 
WM tracts enabled the best differentiation between CI and CP MS patients and also contributed to 
explain deficits of attention and executive functions. 
WM tract damage in MS is partially driven by secondary degenerative phenomena due to 
the presence of focal T2 hyperintense lesions at this level (Henry, et al., 2009; Preziosa, et al., 2012; 
Rocca, et al., 2013), which are another contributor to cognitive dysfunction in these patients 
(Mesaros, et al., 2012). To define the role of focal WM lesions on our findings, we investigated the 
volume and distribution of T2-hyperintense lesions in MS patients based on the presence or not of 
CI. In agreement with previous studies (Rocca, et al., 2015a; Rossi, et al., 2012; Sepulcre, et al., 
2009), CI MS patients had higher T2 LV as well as a higher probability of harboring T2 lesions in 
WM tracts involved in cognitive functions. Despite this, we found only a minimal overlap between 
diffusivity abnormalities and T2 LPMs, thus suggesting that the accumulation of NAWM damage, 
independently from the presence of focal lesions, is relevant for cognitive performances.  
The third important substrate of cognitive impairment in MS patients is atrophy, with a more 
prominent role played by tissue loss in the GM rather than the WM (Rocca, et al., 2015b) and a 
distinct pattern of GM atrophy distribution in CI vs CP patients, involving several cortical regions 
in the frontal, parietal and temporal lobes as well as the thalami and caudate nuclei (Morgen, et al., 
2006; Riccitelli, et al., 2011). This is also substantiated by our results, including the RF analysis, 
which identified atrophy of the left postcentral gyrus and right hippocampus among the best MRI 
variables discriminating CI from CP MS patients. The notion that damage to the GM is more 
clinically relevant for cognition than that of the WM is also supported by the analysis of correlation 
with performance at individual cognitive domains, which demonstrated that atrophy of selected GM 
regions contributed to explain deficit at attention, visual memory, fluency and executive functions, 
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whereas it did not explain verbal memory impairment. Conversely, regional WM atrophy was 
associated with deficits of attention and visual memory only, with atrophy of the posterior part of 
the CC and left ILF identified as the best predictors of impairment of visual memory by the RF 
analysis. The latter finding is in agreement with the results of a recent investigation, which showed 
that damage to the WM, measured using DT MRI, is more clinically relevant that that of the GM to 
explain visual memory deficits (Llufriu, et al., 2014).  
At present, only a few studies have attempted to weight the relative contribution of damage 
to the GM and WM on cognitive impairment in MS patients, providing conflicting results (Hulst, et 
al., 2013; Llufriu, et al., 2014; Sanfilipo, et al., 2006). One study that limited the analysis to global 
WM and GM atrophy (without assessing the regional distribution of such an atrophy) found that 
WM atrophy was the best predictor of mental processing speed and working memory deficits, 
whereas GM atrophy predicted impairment of verbal memory, euphoria, and disinhibition 
(Sanfilipo, et al., 2006). By combining VBM, tract-based spatial statistical analysis and T2 LPMs, a 
recent study showed that CI MS patients diverged from CP ones only for DTI measures of WM 
integrity in areas that are highly relevant for cognition, whereas GM atrophy and T2 lesion 
distribution did not differ between the two groups (Hulst, et al., 2013). By using voxel-wise 
methods to analyze the relative contribution of GM and WM integrity on performance at single 
cognitive tests, another study found that GM damage assessed by DT MRI adds only a small 
increment (less than 5%) to the variance of single neuropsychological tests score attributable to 
WM damage (Llufriu, et al., 2014). Several factors may contribute to explain discrepancies between 
available studies, including differences in the clinical characteristics of the patients enrolled, 
methods used for neuropsychological evaluation, type of imaging modality and analysis methods. 
Our study is not without limitations. First, we did not assess the contribution of cortical 
lesions, which have been associated with the presence and severity of cognitive impairment in MS 
patients (Calabrese, et al., 2010a). However, currently a standardization of this sequence in a 
multicenter setting is lacking. Second, we selected a priori a set of imaging modalities (3D T1 
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weighted and DT MRI scans) which have been proven to be sensitive to some of the pathological 
substrates of MS. As a consequence, we cannot rule out that the use of other imaging modalities 
(e.g., magnetization transfer imaging, MR spectroscopy) would have provided different results. 
Third, the analysis of correspondence between lesional, DTI and atrophy abnormalities was 
based on a visual inspection. A larger sample size and a more specific assessment of the 
heterogeneity of microstructural tissue damage within T2-hyperintense lesions might allow a better 
characterization of the role of focal lesions on cognitive impairment. Fourth, even though patients 
with major depression were excluded, we cannot rule out that other factors, such as mild depression, 
anxiety and fatigue, might have partially influenced our results. 
Future studies should use more sophisticated approaches (such as DT tractography) to assess 
numerical correlations and their reciprocal influence. Longitudinal studies, including patients with 
different clinical phenotypes of the disease, are now warranted to examine the temporal evolution of 
WM and GM damage and their relationship with cognitive impairment and to design rehabilitative 
trials based on multimodal MRI measures. 
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Table 1. Main demographic, clinical and conventional MRI characteristics of healthy controls and 
patients with multiple sclerosis (MS) according to the presence or not of cognitive impairment 
enrolled at seven European centers. 
Group HC MS MS vs HC 
p 
CP CI CI vs CP 
p 
M / F 26 / 35 21 / 40 n.s.* 14 / 24 7 / 16 n.s.* 
Mean age (SD) 
[years] 
36.0 (9.5) 39.7 (8.5) 0.02° 37.5 (7.9) 43.3 (8.4) 0.01° 
Mean education (SD) 
[years]  
16.5 (2.9) 13.7 (3.2) <0.0001° 13.7 (3.1) 13.6 (3.4) n.s.° 
Median EDSS (range) - 1.5 
(0.0-6.0) 
- 1.5  
(0.0-4.0) 
2.0  
(1.0-6.0) 
0.04° 
Mean disease duration 
(SD) [years] 
- 8.2 (6.4) - 7.1 (4.9) 9.9 (8.2) n.s.° 
Mean T2 LV (SD) 
[ml] 
- 10.8 
(14.0) 
- 7.3 (9.7) 16.6 (17.9) 0.01° 
Mean T1 LV (SD) 
[ml] 
- 5.6 (5.9) - 3.7 (3.5) 8.7 (7.6) 0.008° 
Mean NBV (SD) [ml] 1531 (80) 1435 
(108) 
<0.0001° 1460 (99) 1395 (114) 0.02° 
Mean GMV (SD) 
[ml] 
826 (57) 776 (68) <0.0001° 793 (68) 748 (58) 0.01° 
Mean WMV (SD) 
[ml] 
705 (40) 659 (69) <0.0001° 666 (55) 648 (88) n.s.° 
Mean WM FA (SD) 0.47 (0.03) 0.45 
(0.03) 
0.0001° 0.45 (0.02) 0.45 (0.03) n.s.° 
Mean WM MD (SD) 0.76 (0.03) 0.77 
(0.04) 
0.03° 0.77 (0.03) 0.78 (0.05) n.s.° 
Mean GM MD (SD) 0.91 (0.22) 0.97 
(0.22) 
0.02° 0.94 (0.24) 1.02 (0.20) n.s.° 
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HC=healthy controls; CP=cognitively preserved; CI=cognitively impaired; M=male; F=female; 
SD=standard deviation; EDSS=Expanded Disability Status Scale; LV=lesion volume; 
NBV=normalized brain volume; GMV=gray matter volume; WMV=white matter volume; 
WM=white matter; GM=gray matter; FA=fractional anisotropy; MD=mean diffusivity; n..s.=not 
significant. 
Mean MD is expressed in units of mm2/s x 10-3, FA is dimensionless index.  
*Chi-Square Test; °Mann-Whitney Test. 
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Table 2. Brain regions with gray matter (GM) and white matter (WM) atrophy and T2-hyperintense 
lesion differences among the different study groups (p<0.001 uncorrected, ke=5 voxels). 
    
MNI 
coordinates 
 
Comparison Contrast Anatomical region Side x y z t value 
CP MS vs 
HC 
GM 
atrophy 
Thalamus 
R 16 -27 1 6.93* 
L -18 -30 -2 6.67* 
MTG R 65 -35 1 5.33* 
Posterior cingulate cortex L -2 -30 29 4.62 
STG R 63 -44 10 4.52* 
Parahippocampal gyrus R 18 -19 -24 4.16 
Insula L -44 -11 4 4.00 
Caudate nucleus R 21 17 1 3.90 
Caudate nucleus L -10 10 15 3.74 
Calcarine cortex R 6 -63 15 4.30 
MTG L -66 -36 5 4.21 
SFG R 24 57 8 4.02 
Lingual gyrus R 18 -54 -11 4.02 
Cerebellum (lobule 6) R 16 -64 -27 3.41 
IPL R 56 -47 42 4.00 
Precentral gyrus L -24 -10 64 3.98 
MFG L -26 46 11 3.95 
IFG R 37 20 -15 3.90 
IPL L -58 -53 42 3.79 
Cerebellum (lobule 6) L -23 -61 -32 3.79 
  
23 
Precentral gyrus R 29 -4 52 3.68 
SPL R 27 -61 50 3.56 
SFG L -1 56 22 3.52 
Hippocampus L -23 -13 -24 3.51 
SPL L -77 45 3.29 -24 
WM 
atrophy 
Fornix L/R 0 -5 13 5.89* 
ATR R 26 -33 1 5.66* 
ATR L -29 -30 -6 5.18* 
Body of the CC L -5 -16 24 4.98* 
Body of the CC R 6 -17 24 4.97* 
ILF R 45 -7 -13 4.90* 
Posterior cingulum L -10 -19 36 4.86* 
SLF R 55 -38 21 4.65* 
IFOF R 45 -24 -11 4.63* 
Forceps minor L -19 46 22 3.84 
SLF L -52 -55 38 3.58 
ILF L -28 -81 -4 3.36 
CI MS vs 
HC 
GM 
atrophy 
Thalamus L -16 -29 -1 8.12* 
Thalamus R 18 -29 -1 7.92* 
Posterior cingulate cortex L -0 -33 27 5.91* 
Precuneus  R 3 -62 17 5.41* 
Posterior cingulate cortex R 2 -36 28 5.26* 
Putamen R 32 -2 1 5.01* 
Putamen L -19 9 3 4.98* 
Caudate nucleus R 13 3 20 4.82* 
  
24 
IPL L -40 -37 45 4.76* 
Amygdala R 31 3 -18 4.71 
Caudate nucleus L -10 8 15 4.63 
Insula L -53 -9 8 4.63 
Amygdala L -10 -8 -15 4.46 
ITG L -58 -10 -15 4.45 
MTG L -54 -60 1 4.27 
Cerebellum (lobule 6) R 21 -59 -9 4.17 
Insula R 48 -27 8 4.09 
STG R 61 -35 1 5.10* 
MOG L -29 -87 12 4.54 
MTG R 47 -21 -25 4.13 
MFG L -24 -4 48 4.13 
Precentral gyrus R 39 -11 47 3.98 
STG L -62 -38 5 3.96 
Postcentral gyrus L -45 -19 34 3.79 
Cerebellum (left crus I) L -45 -54 -25 3.70 
Postcentral gyrus R 21 -42 61 3.51 
Precentral gyrus L -32 -17 45 3.50 
SPL R 27 -60 49 3.48 
SMA L -2 24 57 3.45 
IFG R 44 8 25 3.29 
WM 
atrophy 
Fornix L/R 0 0 3 8.08* 
ATR R 19 -33 8 8.08* 
ATR L -32 -24 -6 7.55* 
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Forceps major L -13 -38 15 6.38* 
Splenium of the CC L -10 -41 19 6.32* 
Body of the CC L -7 -19 24 6.27* 
SLF L -34 -46 20 6.27* 
Body of the CC R 8 -19 24 6.26* 
ILF L -37 -60 1 6.25* 
SLF R 44 -46 1 6.18* 
Posterior cingulum L -13 -47 22 6.17* 
Splenium of the CC R 18 -47 22 6.05* 
ILF R 40 -8 -17 6.02* 
Posterior corona radiata L -21 -28 36 5.86* 
IFOF R 35 -55 14 5.60* 
CI vs CP 
MS 
T2 LPM 
IFOF L -37 -44 -6 5.84* 
Forceps major L -24 -55 3 4.42 
ATR L -24 -31 22 4.27 
SLF R 34 -31 36 4.69 
IFOF R 35 -44 10 4.39 
Forceps major R 22 -55 12 3.88 
Splenium of the CC R 26 -52 8 3.59 
Body of the CC R 3 14 20 4.45 
Forceps minor L -10 33 -13 4.16 
ATR R 3 -19 -6 4.27 
Posterior cingulum L -20 -49 31 4.20 
ILF R 21 -59 -4 4.19 
Middle cingulum L -11 -27 31 4.04 
  
26 
Splenium of the CC R 14 -43 29 3.99 
Anterior cingulum R 8 24 27 3.85 
SCP R 6 -48 -27 3.79 
Corona radiata R 21 -8 34 3.53 
Genu of the CC R 15 33 9 3.32 
GM 
atrophy 
Postcentral gyrus 
R 23 -42 56 3.51 
L -45 -17 38 3.26 
Thalamus L -16 -27 1 3.48 
Supramarginal gyrus L -45 -38 36 3.41 
Hippocampus R 29 -30 -2 3.32 
WM 
atrophy 
ILF L -34 -60 8 4.22 
IFOF L -34 -32 3 4.14 
ATR R 18 -32 8 4.07 
Posterior cingulum L -11 -43 22 3.86 
SLF L -31 -36 22 3.83 
Splenium of the CC R 11 -39 17 3.61 
Fornix L/R 0 0 3 3.87 
ILF R 37 -55 12 3.46 
Uncinate fasciculus R 36 10 -34 3.32 
Conjunction 
analysis 
CI MS vs 
(HC and CP 
MS) 
GM 
atrophy 
Thalamus L -16 -27 1 3.48 
Supramarginal gyrus L -45 -38 36 3.41 
Hippocampus R 29 -30 -2 3.32 
SPL R 26 -42 54 3.28 
Postcentral gyrus L -45 -17 38 3.26 
WM ILF L -34 -60 8 4.22 
  
27 
atrophy IFOF L -34 -32 3 4.14 
ATR R 18 -32 8 4.07 
Posterior Cingulum L -11 -43 22 3.86 
SLF L -31 -36 22 3.83 
Splenium of the CC R 11 -39 17 3.61 
Fornix L/R 0 0 3 3.87 
ILF R 37 -55 12 3.46 
Uncinate fasciculus R 36 10 -34 3.32 
 
HC=healthy controls; MS=multiple sclerosis;CP=cognitively preserved; CI=cognitively impaired; 
MNI=Montreal Neurological Institute; GM=gray matter; WM=white matter; LPM=lesion 
probability map; R=right, L=left; MTG=middle temporal gyrus; STG=superior temporal gyrus; 
SFG=superior frontal gyrus; IPL= inferior parietal lobule; MFG=middle frontal gyrus; IFG=inferior 
frontal gyrus; SPL=superior parietal lobule; ATR=anterior thalamic radiation; CC=corpus callosum; 
ILF=inferior longitudinal fasciculus; SLF=superior longitudinal fasciculus; IFOF=inferior fronto-
occipital fasciculus; ITG=inferior temporal gyrus; MOG=middle occipital gyrus; 
SMA=supplementary motor area; SCP=superior cerebellar peduncle. 
*p<0.05 FWE corrected for multiple comparisons. 
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Table 3. Normal appearing white matter regions with mean diffusivity and fractional anisotropy 
differences among the different study groups (p<0.05 FWE corrected for multiple comparisons, 
ke=5 voxels). 
    MNI coordinates  
Comparison Contrast Anatomical region Side x y z t value 
CP MS vs 
HC 
MD 
increase 
ILF R 45 -4 -16 6.11 
Corona radiata L -25 -9 36 5.39 
Splenium of the CC R 9 -36 8 5.28 
Body of the CC L -7 0 29 5.26 
SLF L -54 -22 6 5.00 
Corona radiata R 22 -23 37 4.95 
ILF R 45 -36 -9 4.82 
Posterior cingulum R 25 -32 -13 4.79 
ATR L -23 29 19 4.76 
SLF R 49 -38 0 4.76 
Anterior cingulum R 6 15 24 4.73 
FA 
decrease 
IFOF L -32 -22 -6 6.51 
ILF L -35 -58 5 6.47 
Posterior corona radiata R 24 -23 28 6.19 
IFOF R 31 -36 22 5.32 
SLF R 39 -13 25 5.16 
ILF R 44 -32 -9 6.00 
Fornix L -1 1 4 5.60 
Posterior corona radiata L -21 -29 30 5.38 
SLF L -30 -15 27 4.88 
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Posterior cingulum L -11 -17 38 5.36 
MCP R 12 -41 -30 5.36 
MCP L -18 -37 -29 5.28 
Posterior cingulum R 24 -28 -12 5.11 
Anterior cingulum L -12 18 28 5.02 
CI MS vs 
HC 
MD 
increase 
Posterior cingulum L -7 -25 41 10.50 
Posterior corona radiata L -23 -48 26 10.48 
Posterior cingulum R 10 -28 39 9.18 
SLF L -40 -2 43 8.99 
SLF R 40 15 24 8.63 
IFOF L -33 -13 -7 8.45 
Forceps major R 25 -54 19 8.27 
Splenium of the CC R 13 -44 13 8.27 
SLF R 31 -39 27 8.11 
Forceps major L -2 -35 14 7.95 
Splenium of the CC L -13 -45 13 7.86 
Body of the CC R 7 -24 26 7.78 
Anterior corona radiata R 24 -9 50 7.69 
MCP L -12 -30 -29 6.16 
MCP R 17 -32 -35 6.11 
IFOF R 17 -83 -2 5.72 
Forceps minor L -11 55 6 5.70 
Uncinate fasciculus R 33 -1 -22 4.70 
FA 
decrease 
IFOF L -34 -19 -8 9.30 
ILF L -36 -53 -4 8.92 
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ILF R 35 -54 9 8.55 
Posterior corona radiata R 16 -25 67 8.54 
Posterior cingulum R 11 -7 39 7.83 
Forceps major R 25 -63 18 7.79 
Posterior cingulum L -23 -31 -16 7.75 
SLF R 34 -15 22 7.60 
SLF L -49 16 10 7.51 
Body of the CC R 2 18 17 7.21 
ATR L -14 -19 -4 7.21 
Forceps major L -22 -66 18 7.18 
Body of the CC L -5 -24 26 7.17 
MCP R 8 -45 -33 6.65 
Uncinate fasciculus L -39 32 -7 5.93 
 Forceps minor R 12 51 -9 5.08 
CI vs CP MS 
MD 
increase 
Posterior cingulum L -7 -25 41 8.30 
Posterior corona radiata L -24 -47 26 8.00 
Splenium of the CC L -2 -34 15 5.51 
SLF L -40 -3 43 7.15 
IFOF L -33 -13 -7 6.74 
Posterior cingulum R 9 -27 39 6.73 
Splenium of the CC R 12 -44 13 5.88 
IFOF R 31 -38 25 5.29 
SLF R 39 15 23 5.81 
Anterior cingulum L -5 19 31 5.72 
Forceps minor R 12 41 10 5.62 
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Anterior cingulum R 9 31 37 5.45 
Uncinate fasciculus R 29 16 -6 5.25 
ATR L -37 34 9 5.23 
Uncinate fasciculus L -30 18 3 4.87 
FA 
decrease 
IFOF L -28 -45 24 6.19 
IFOF R 30 -55 19 5.43 
SLF L -47 13 5 5.38 
Anterior cingulum R 8 -3 39 5.12 
Conjunction 
analysis 
CI MS vs 
(HC and CP 
MS) 
MD 
increase 
Posterior cingulum L -7 -25 41 8.30 
Posterior corona radiata L -19 -26 51 4.95 
Posterior corona radiata L -24 -47 26 8.00 
Splenium of the CC L -2 -34 15 5.51 
SLF L -40 -3 43 7.15 
IFOF L -33 -13 -7 6.74 
Posterior cingulum R 9 -27 39 6.73 
Splenium of the CC R 12 -44 13 5.88 
IFOF R 31 -38 25 5.29 
SLF R 39 15 23 5.81 
Anterior cingulum L -5 19 31 5.72 
Forceps minor R 12 41 10 5.62 
Anterior cingulum R 9 31 37 5.45 
Uncinate fasciculus R 29 16 -6 5.25 
ATR L -37 34 9 5.23 
Uncinate fasciculus L -30 18 3 4.87 
FA IFOF L -28 -45 24 6.19 
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decrease ILF R 30 -55 19 5.43 
SLF L -47 13 5 5.38 
Anterior cingulum R 8 -3 39 5.12 
 
HC=healthy controls; MS=multiple sclerosis; CP=cognitively preserved; CI=cognitively impaired; 
MNI=Montreal Neurological Institute; MD=mean diffusivity; FA=fractional anisotropy; R=right, 
L=left; ILF=inferior longitudinal fasciculus; CC=corpus callosum; SLF=superior longitudinal 
fasciculus; IFOF=inferior fronto-occipital fasciculus; ATR=anterior thalamic radiation; 
MCP=middle cerebellar peduncle. 
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Table 4. Brain regions with gray matter and white matter atrophy correlated to performance at 
different cognitive domains (z scores) and number of errors at Wisconsin Card Sorting Test 
(WCST) (p<0.001 uncorrected, ke=5 voxels). 
    MNI coordinates   
Cognitive 
domain 
Contrast Anatomical region Side x y z t value 
r 
value 
Attention 
(z score) 
GM 
atrophy 
Putamen L -29 5 -4 5.53* 0.69 
Putamen R 19 19 3 5.49* 0.69 
Caudate nucleus R 11 21 4 5.45* 0.68 
Thalamus L -15 -25 -2 4.77 0.63 
Thalamus R 6 -8 -3 4.71 0.63 
Hippocampus L -19 -18 -11 4.28 0.59 
Amygdala L -13 -10 -13 4.25 0.59 
Amygdala R 21 3 -18 4.23 0.59 
Insula L -40 13 -1 4.07 0.57 
Caudate nucleus L -15 -8 24 4.03 0.57 
Posterior cingulate cortex L -3 -41 19 5.32* 0.68 
Precuneus R 3 -62 14 4.07 0.57 
MOG L -41 -66 24 3.89 0.56 
Precentral gyrus R 44 -8 36 3.84 0.55 
STG R 55 -36 14 3.81 0.55 
MTG R 53 -37 -4 3.78 0.54 
IFG R 41 32 17 3.71 0.54 
Anterior cingulate cortex R 13 -7 48 3.64 0.53 
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STG L -52 -22 -6 3.43 0.51 
MFG L -34 46 2 3.43 0.51 
WM 
atrophy 
Posterior cingulum L -5 -49 21 5.54* 0.69 
ATR L -7 -16 13 4.85* 0.64 
Body of the CC R 5 -22 26 4.65 0.62 
IFOF R 38 -8 -18 4.50 0.61 
ATR R 5 20 -5 4.34 0.60 
IFOF L -26 28 2 4.25 0.59 
ILF L -39 -11 -24 4.22 0.59 
SLF L -36 8 13 4.08 0.57 
ILF R 37 -27 -15 4.06 0.57 
Posterior corona radiata L -21 -28 54 4.13 0.58 
SLF R 43 -51 5 3.57 0.52 
Visual 
memory 
(z score) 
GM 
atrophy 
MFG L -37 47 4 4.39 0.57 
Postcentral gyrus L -31 -39 45 4.01 0.53 
ITG R 53 -40 -16 3.99 0.53 
Precuneus R 6 -58 70 3.98 0.53 
MTG R 65 -24 -16 3.90 0.52 
IFG R 49 35 4 3.88 0.52 
Precentral gyrus R 50 3 24 3.67 0.50 
Posterior cingulate cortex R 10 -38 5 3.63 0.50 
Precentral gyrus L -47 -6 31 3.57 0.49 
Amygdala R 16 -7 -11 3.51 0.48 
MFG L -34 32 25 3.44 0.48 
Posterior cingulate cortex L -7 -28 38 3.40 0.48 
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WM 
atrophy 
SLF R 47 -57 26 5.08* 0.62 
ILF R 47 -37 -13 4.29 0.56 
Posterior cingulum L -5 -25 33 4.26 0.56 
Posterior corona radiata L -18 -42 52 4.23 0.55 
IFOF R 37 -19 -2 4.19 0.55 
ILF L -19 -50 54 4.10 0.54 
Splenium of the CC R 5 -36 24 3.82 0.52 
SLF L -34 -30 31 3.74 0.51 
Splenium of the CC L -10 -36 20 3.70 0.50 
Forceps major L -10 -41 6 3.44 0.48 
Verbal 
memory 
(z score) 
GM 
atrophy 
- - - - - - - 
WM 
atrophy 
- - - - - - - 
Fluency 
(z score) 
GM 
atrophy 
Precentral gyrus L -5 -29 77 3.68 0.57 
Postcentral gyrus L -44 -26 43 3.64 0.56 
MTG R 68 -10 -16 3.62 0.56 
Insula R 39 6 -4 3.58 0.56 
Insula L -40 19 -8 3.41 0.54 
WM 
atrophy 
- - - - - - - 
Executive 
functions 
(WCST 
number 
GM 
atrophy 
IFG R 44 33 -5 4.20 0.65 
Thalamus L -3 -9 15 4.20 0.65 
Thalamus R 6 -24 15 3.48 0.58 
Anterior cingulate cortex L -6 16 41 4.11 0.65 
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of errors) 
 
SFG R 7 49 2 3.37 0.57 
Caudate nucleus R 15 5 25 3.34 0.57 
Posterior cingulate cortex R 3 -36 27 3.33 0.57 
WM 
atrophy 
- - - - - - - 
 
MNI=Montreal Neurological Institute; GM=gray matter; WM=white matter; R=right, L=left; 
MTG=middle temporal gyrus; MOG=middle occipital gyrus; STG=superior temporal gyrus; 
IFG=inferior frontal gyrus; MFG=middle frontal gyrus; ATR=anterior thalamic radiation; 
CC=corpus callosum; IFOF=inferior fronto-occipital fasciculus; ILF=inferior longitudinal 
fasciculus; SLF=superior longitudinal fasciculus; ITG=inferior temporal gyrus; SFG=superior 
frontal gyrus. 
*p<0.05, FWE corrected for multiple comparisons.
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Table 5. Normal-appearing white matter regions with mean diffusivity and fractional anisotropy 
values correlated to performance at different cognitive domains (z scores) and number of errors at 
Wisconsin Card Sorting Test (WCST) (p<0.001 uncorrected, ke=5 voxels). 
 
    MNI coordinates   
Cognitive 
domain 
Contrast Anatomical region Side x y z t value 
r 
value 
Attention 
(z score) 
MD 
increase 
Uncinate fasciculus L -28 21 12 5.22* -0.66 
Anterior cingulum R 13 17 38 5.13* -0.66 
Uncinate fasciculus R 26 19 -7 5.03* -0.65 
Posterior cingulum R 11 -15 39 4.93* -0.64 
Posterior cingulum L -13 -24 36 4.72 -0.63 
IFOF L -25 23 -1 4.72 -0.63 
ATR L -11 2 5 4.65 -0.62 
Body of the CC R 14 -13 33 4.54 -0.61 
SLF L -52 -41 -14 4.90 -0.64 
SLF R 52 -54 2 4.56 -0.61 
IFOF R 26 -84 -10 3.78 -0.54 
FA 
decrease 
SLF L -49 -34 -13 5.90* 0.71 
ATR L -4 -12 7 5.80* 0.70 
Forceps minor R 19 51 21 5.58* 0.69 
Body of the CC R 3 -21 26 5.58* 0.69 
Posterior corona radiata L -21 -26 53 5.57* 0.69 
ILF R 40 -2 -34 5.17* 0.66 
IFOF L -32 -25 4 5.15* 0.66 
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SLF R 41 9 16 4.97 0.65 
Forceps major R -16 -89 20 4.12 0.57 
Posterior corona radiata R 17 -34 67 3.90 0.55 
ILF L -48 7 -17 3.63 0.53 
Visual 
memory 
(z score) 
MD 
increase 
Posterior cingulum L -8 -27 30 4.55 -0.58 
Splenium of the CC L -16 -35 29 4.05 -0.53 
Posterior corona radiata L -25 -17 33 4.05 -0.53 
SLF R 47 -46 34 3.94 -0.52 
Posterior cingulum R 8 -30 30 3.89 -0.52 
Posterior corona radiata R 25 -43 28 3.73 -0.50 
Forceps minor R 17 38 12 3.72 -0.50 
SLF L -42 -34 6 3.64 -0.49 
ATR L -16 3 6 3.64 -0.49 
Forceps major R 16 -81 4 3.51 -0.48 
Uncinate fasciculus R 18 9 -10 3.50 -0.48 
FA 
decrease 
IFOF L -24 -74 -3 5.36* 0.64 
ILF L -29 -87 9 4.55 0.58 
ATR L -18 4 7 4.53 0.57 
Posterior cingulum L -22 -48 -3 4.53 0.57 
Forceps major L -16 -82 4 4.33 0.56 
SLF L -58 -28 -14 4.07 0.53 
Forceps major R 18 -81 9 5.13 0.62 
IFOF R 27 -71 -2 4.18 0.54 
Anterior cingulum R 14 27 31 4.80 0.60 
Body of the CC R 1 -2 28 4.11 0.54 
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Forceps minor R 16 42 15 3.89 0.52 
Body of the CC L -4 -24 28 3.58 0.48 
Posterior corona radiata R 33 -24 58 4.77 0.59 
SLF R 37 -12 22 4.38 0.56 
Verbal 
memory 
(z score) 
MD 
increase 
- - - - - - - 
FA 
decrease 
- - - - - - - 
Fluency 
(z score) 
MD 
increase 
- - - - - - - 
FA 
decrease 
- - - - - - - 
Executive 
functions 
(WCST 
number of 
errors) 
MD 
increase 
ILF R 35 -63 -12 4.34 -0.66 
SLF L -38 -14 33 4.04 -0.63 
Forceps major R 19 -88 19 4.03 -0.63 
Anterior cingulum R 7 37 19 3.99 -0.63 
Splenium of the CC R 10 -42 7 3.86 -0.62 
SLF R 49 -45 35 3.77 -0.61 
IFOF R 31 2 -5 3.71 -0.60 
Body of the CC R 9 -20 24 3.66 -0.60 
IFOF L -30 -4 -3 3.64 -0.59 
FA 
decrease 
IFOF R 43 36 6 4.56 0.68 
SLF R 54 -8 35 4.41 0.67 
Uncinate fasciculus L -39 34 12 3.87 0.62 
SLF L -50 -3 37 3.56 0.59 
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MNI=Montreal Neurological Institute; MD=mean diffusivity; FA=fractional anisotropy; R=right, 
L=left; IFOF=inferior fronto-occipital fasciculus; ATR=anterior thalamic radiation; CC=corpus 
callosum; ILF=inferior longitudinal fasciculus; SLF=superior longitudinal fasciculus. 
*p<0.05, FWE corrected for multiple comparisons. 
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Figure legends 
 
Figure 1. Statistical parametric mapping (SPM) analysis showing regions of gray matter (GM) 
(yellow coded) and white matter (WM) (blue coded) volume loss and T2 lesion probability maps 
(LPMs) differences (red-coded) superimposed on the customized GM template (p<0.001 
uncorrected; cluster extent=5 voxels): a) GM and WM atrophy in cognitively preserved (CP) MS 
patients vs healthy controls (HC); b) GM and WM atrophy in cognitively impaired (CI) MS patients 
vs HC; c) GM and WM atrophy and regions with higher T2 occurrence in CI vs CP MS patients; d) 
GM and WM atrophy in CI MS patients vs both HC and CP MS patients. See text for further 
details. Images are in neurological convention (right side of the images is right side of the brain). 
 
Figure 2. Statistical parametric mapping (SPM) analysis showing regions with increased mean 
diffusivity (MD) (blue-coded), reduced fractional anisotropy (FA) (green-coded) and T2 lesion 
probability maps (LPMs) differences (red-coded) superimposed on the customized FA template 
(p<0.05 family-wise error corrected for multiple comparisons; cluster extent=5 voxels): a) 
significantly increased MD and decreased FA in cognitively preserved (CP) MS patients vs healthy 
controls (HC); b) significantly increased MD and decreased FA in cognitively impaired (CI) MS 
patients vs HC; c) significantly increased MD and decreased FA and regions with higher T2 lesion 
occurrence in CI vs CP MS patients (the overlaps between diffusivity differences and T2 LPMs 
differences are yellow-coded); d) significantly increased MD and decreased FA in CI MS patients 
vs both HC and CP MS patients. See text for further details. Images are in neurological convention 
(right side of the images is right side of the brain). 
 
Figure 3. Statistical parametric mapping (SPM) analysis showing regions with gray matter (GM) 
(yellow coded) and white matter (WM) (blue coded) atrophy in multiple sclerosis patients 
significantly correlated to performance at different cognitive domains (p<0.001 uncorrected; cluster 
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extent=5 voxels). Results are superimposed on the customized GM template. See text for further 
details. Images are in neurological convention (right side of the images is right side of the brain). 
WCST=Wisconsin Card Sorting Test. 
 
Figure 4. Statistical parametric mapping (SPM) analysis showing regions with mean diffusivity 
(MD) (blue-coded) and fractional anisotropy (FA) (green-coded) being correlated to the 
performance at the different cognitive domains superimposed on the customized FA template in 
multiple sclerosis (MS) patients (p<0.001 uncorrected; cluster extent=5). 
 
Figure 5. Results of the random forest analysis. Normalized variable importance, ranging from 0 
(the less important) to 100 (the most important), of the five most important MRI variables in 
predicting global and specific cognitive scores. CI=cognitively impaired; CP=cognitively 
preserved; MS=multiple sclerosis; L=left; R=right; SLF=superior longitudinal fasciculus; 
FA=fractional anisotropy; MD=mean diffusivity; ILF=inferior longitudinal fasciculus; IFG=inferior 
frontal gyrus; CC=corpus callosum; MTG=middle temporal gyrus; IFOF=inferior fronto-occipital 
fasciculus.  
 
 
